Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicity
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (2), 283-289
- https://doi.org/10.1016/0006-2952(90)90689-i
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituentJournal of Medicinal Chemistry, 1989
- Characterization of mcf 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolitesThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Effects of Tamoxifen, Tamoxifen Metabolites, and Nafoxidine on Adenosine 3′,5′-Monophosphate Phosphodiesterase: Correlations with Growth Inhibitory Activities but not Estrogen Receptor Affinities*Endocrinology, 1989
- Calmodulin as a Target for New Chemotherapeutic StrategiesCancer Investigation, 1988
- Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cellsJournal of Steroid Biochemistry, 1987
- Stereoselective olefin formation from the dehydration of 1-(p-alkoxyphenyl)-1,2-diphenylbutan-1-ols: application to the synthesis of tamoxifenJournal of the Chemical Society, Perkin Transactions 1, 1986
- Structure-activity relationships of calmodulin antagonism by tryphenylethylene antiestrogensBiochemical Pharmacology, 1986
- Differential Effects of Tamoxifen and Analogs with Nonbasic Side Chains on Cell Proliferationin VitroEndocrinology, 1985
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Physiological implications of the presence, distribution, and regulation of calmodulin in eukaryotic cells.Physiological Reviews, 1982